Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders. - Wikidata - wikimedia - TriplyDB

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders.

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders.

http://www.wikidata.org/entity/Q37965882

about

Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy.A new therapeutic assessment score for advanced hepatocellular carcinoma patients receiving hepatic arterial infusion chemotherapy.Newer treatments for advanced hepatocellular carcinoma.Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma.Efficacy of iron chelator deferoxamine for hepatic arterial infusion chemotherapy in advanced hepatocellular carcinoma patients refractory to current treatments.Clinical outcome of sorafenib treatment in patients with advanced hepatocellular carcinoma refractory to hepatic arterial infusion chemotherapy.A randomized study of cisplatin and 5-FU hepatic arterial infusion chemotherapy with or without adriamycin for advanced hepatocellular carcinoma.Treatment strategies for advanced hepatocellular carcinoma: Sorafenib hepatic arterial infusion chemotherapy Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study

P2860

Q28066295-4C981BB9-6711-4E34-8C07-0B63F8349F7F Q33410974-FB0F61D4-EAE0-488E-B606-DD26E082334B Q35629299-148A744F-A1F0-431B-97CB-86CAC92029F0 Q37642185-A9B19C6F-45A7-42B0-8B92-00830E96277B Q38410821-FE7A6E86-72C4-4BE6-ACCC-F52392C088CA Q38982079-7671FA71-4240-4250-8F44-739F7C753D1A Q44769237-A56686F5-2E15-4EAB-B6B5-91D23A8A87CD Q53615583-CB1ED28E-6E14-4897-B5F0-B3DB38B3BCCB Q57491231-30C249B8-3B12-4B39-A9AB-69EF9F31E74E Q59129080-89480599-6DB7-44C8-9F3E-9C2E3A8DE6A8

P2860

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma and future treatments for the poor responders.

http://www.wikidata.org/entity/Q37965882

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Hepatic arterial infusion chem ...... ments for the poor responders.

@en

Hepatic arterial infusion chem ...... ments for the poor responders.

@nl

type

label

Hepatic arterial infusion chem ...... ments for the poor responders.

@en

Hepatic arterial infusion chem ...... ments for the poor responders.

@nl

prefLabel

Hepatic arterial infusion chem ...... ments for the poor responders.

@en

Hepatic arterial infusion chem ...... ments for the poor responders.

@nl

P1433

Q37965882-9915F392-CB18-42D8-8E2A-DF2ED6B180BC

P1476

Q37965882-43E8BE05-547B-4233-808D-F741E75BA922

P2093

Q37965882-9A8BD9AE-4DD4-4962-9198-B7467E198567

Q37965882-B75F5C1D-39E8-4C51-84CC-A45D1F3C12A4

P2860

Q37965882-0D405CD5-FD9B-4F08-B6F6-3855DEE4742B

Q37965882-0E7EC31C-63FE-4D64-91AD-8C19410A5A19

Q37965882-108155FB-162E-4984-A8F6-56AA945975FF

Q37965882-12434A17-E93A-4ED8-8708-D8D9B10978BC

Q37965882-151E640B-3D86-4737-A6E8-703D4C67FC95

Q37965882-1A41914C-3DF1-4B2A-9275-3861D2074FCD

Q37965882-1A88F9F2-5B15-46AB-8FEA-11D7E404A91A

Q37965882-25A21025-20D1-4CAF-8397-7D796F0E2864

Q37965882-2A3F78DD-3698-414D-BF0F-1F54F90232F6

Q37965882-31EDBAF4-6C93-47EA-8E45-2D06C007D18C

P304

Q37965882-396EA0C0-B94D-4C45-B14C-EFEBE6B24E86

P31

Q37965882-3835D826-D349-4446-A96C-8A251907B016

P356

Q37965882-E230A8B3-B84F-4186-9901-D3BC3550E639

P433

Q37965882-CBC8468D-CB3F-4685-96B3-D1208CC9FF4B

P478

Q37965882-DC1ED201-3229-41F5-B24A-F2BEDEE1FFA3

P577

Q37965882-7FBD6559-3D93-4502-8DAC-660DB6E56BB3

P698

Q37965882-5F5785DB-F0B4-4D2B-A1FD-1C9AA41C425C

P921

Q37965882-97D84C18-389A-47C7-9B21-EA333CC09D27

P356

J.1872-034X.2011.00938.X

P1433

Hepatology Research

P1476

Hepatic arterial infusion chem ...... ments for the poor responders.

@en

P2093

Isao Sakaida

http://www.w3.org/2001/XMLSchema#string

Takahiro Yamasaki

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning of transferrin receptor 2. A new member of the transferrin receptor-like family

Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C

Treatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expression

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

Sorafenib in advanced hepatocellular carcinoma

Influence of non-enzymatic post-translation modifications on the ability of human serum albumin to bind iron. Implications for non-transferrin-bound iron speciation

Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Management of hepatocellular carcinoma

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

P304

340-348

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1872-034X.2011.00938.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22151009

http://www.w3.org/2001/XMLSchema#string

P921